P

Inventor

CAMERON MARK

US13 patents
⚠️ This page may combine multiple inventors who share the name “CAMERON MARK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MERCK & CO INC

4 patents
US6355611B1Mar 12, 2002

Salt form of a conjugate useful in the treatment of prostate cancer

MERCK & CO INC7 citations71
US6063931AMay 16, 2000

Process for synthesizing carbapenem side chain intermediates

MERCK & CO INC14 citations71
US6060607AMay 9, 2000

Process for synthesizing carbapenem side chain intermediates

MERCK & CO INC13 citations71
US7598264B2Oct 6, 2009

HIV integrase inhibitors

MERCK & CO INC7 citations59

(unassigned)

2 patents
US6708597B2Mar 23, 2004

Weapon aiming

16 citations91
US6460447B1Oct 8, 2002

Weapon aiming

14 citations83

SILENCE THERAPEUTICS GMBH

2 patents
US10913945B2Feb 9, 2021

Nucleic acid linked to a trivalent glycoconjugate

SILENCE THERAPEUTICS GMBH2 citations71
US11912993B2Feb 27, 2024

Nucleic acid linked to a trivalent glycoconjugate

SILENCE THERAPEUTICS GMBH0 citations61

CAMERON MARK

2 patents
US8408745B2Apr 2, 2013

Illuminating and targeting systems and methods having variable liquid lens

CAMERON MARK2 citations55
US9181295B2Nov 10, 2015

Cationic lipids with various head groups for oligonucleotide delivery

CAMERON MARK0 citations45

MERCK SHARP & DOHME

1 patent
US5681959AOct 28, 1997

Chemical synthesis of azaindoles

MERCK SHARP & DOHME84 citations92

SIRNA THERAPEUTICS INC

1 patent
US9642804B2May 9, 2017

Cationic lipids with various head groups for oligonucleotide delivery

SIRNA THERAPEUTICS INC4 citations70

US HEALTH

1 patent
US10398772B2Sep 3, 2019

Ras pathways as markers of protection against HIV and methods to improve vaccine efficacy

US HEALTH0 citations38